Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7619310 | 1.00 | KDM1A (0.47) | KDM1AMAOBHDAC9PNMTTSHR | |
| SCHEMBL11696762 | 0.90 | KDM1A (0.54) | KDM1ATSHRTP53CYP1A2CYP3A4 | |
| SCHEMBL6267106 | 0.79 | KDM1A (0.53) | KDM1AMAOBHDAC9TSHRALDH1A1 | |
| SCHEMBL29784907 | 0.79 | KDM1A (0.53) | KDM1AMAOBHDAC9TSHRALDH1A1 | |
| SCHEMBL11883933 | 0.78 | KDM1A (0.46) | KDM1AMAOBTSHRALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL29189207 | 0.77 | KDM1A (0.52) | KDM1AMAOBHDAC9TSHRALDH1A1 | |
| SCHEMBL11166802 | 0.77 | HTR2A (0.47) | KDM1AMAOBHDAC9PNMT | |
| SCHEMBL30112838 | 0.75 | KDM1A (0.59) | KDM1AMAOBTSHRTP53CYP1A2 | |
| SCHEMBL1101137 | 0.75 | KDM1A (0.59) | KDM1AMAOBTSHRTP53CYP1A2 | |
| SCHEMBL6337745 | 0.75 | HDAC9 (0.49) | KDM1AMAOBHDAC9TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993011114-A1 | AMINE ANTIDEGRADANTS FOR UNSATURATED POLYMERS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0143075-B1 | PROCESS FOR THE PREPARATION OF N-GLYCIDYL COMPOUNDS | CIBA-GEIGY AG (CH) | 1987-11-19 | — | — | EP | claimed |
| EP-0099338-B1 | EPOXY RESIN SYSTEMS MODIFIED WITH THERMOPLASTIC RESINS | CIBA-GEIGY AG (CH) | 1986-05-14 | — | — | EP | claimed |
| US-4540769-A | NITRATE, PERCHLORATE, ALPHA-HALO CARBOXYLATE OR SULFONATE | CIBA-GEIGY CORPORATION (US) | 1985-09-10 | — | — | US | claimed |
| EP-0143075-A1 | Process for the preparation of N-glycidyl compounds | CIBA-GEIGY AG (CH) | 1985-05-29 | — | — | EP | claimed |
| EP-3762431-A1 | ETHYLENE-PROPYLENE LINEAR COPOLYMERS AS VISCOSITY MODIFIERS | ExxonMobil Chemical Patents Inc. (US) | 2021-01-13 | — | — | EP | disclosed |
| WO-2019173598-A1 | ETHYLENE-PROPYLENE LINEAR COPOLYMERS AS VISCOSITY MODIFIERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-09-12 | — | — | WO | disclosed |
| US-8076495-B2 | Aromatic N-glycidylamines by catalysis of an aromatic aminehydrogen and epichlorohydrin using a lanthanum nitrate as a catalyst dissolved in propylene carbonate, then dehydrochlorinating | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2011-12-13 | — | — | US | disclosed |
| US-20080221342-A1 | Process | HUNTSMAN ADVANCED MATERIALS AMERICANS INC. (US) | 2008-09-11 | — | — | US | disclosed |
| CN-100400525-C | Process for the preparation of n-glycidylamines | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2008-07-09 | — | — | CN | disclosed |
| EP-1656363-B1 | PROCESS FOR THE PREPARATION OF N-GLYCIDYLAMINES | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2007-10-10 | — | — | EP | disclosed |
| CN-1812976-A | Process for the preparation of n-glycidylamines | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2006-08-02 | — | — | CN | disclosed |
| EP-1656363-A2 | PROCESS FOR THE PREPARATION OF N-GLYCIDYLAMINES | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005003109-A2 | PROCESS FOR THE PREPARATION OF N-GLYCIDYLAMINES | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2005-01-13 | — | — | WO | disclosed |
| US-6011070-A | TREATING AN INDIVIDUAL WHO ABUSES COCAINE, AN INDIVIDUAL WITH PARKINSON'S DISEASE OR AN INDIVIDUAL WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER | ALLELIX-PHARM-ECO L.P. (US) | 2000-01-04 | — | — | US | disclosed |
| WO-1993011114-A1 | AMINE ANTIDEGRADANTS FOR UNSATURATED POLYMERS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1993-06-10 | — | — | WO | disclosed |
| EP-0143075-B1 | PROCESS FOR THE PREPARATION OF N-GLYCIDYL COMPOUNDS | CIBA-GEIGY AG (CH) | 1987-11-19 | — | — | EP | disclosed |
| US-4540769-A | NITRATE, PERCHLORATE, ALPHA-HALO CARBOXYLATE OR SULFONATE | CIBA-GEIGY CORPORATION (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0143075-A1 | Process for the preparation of N-glycidyl compounds | CIBA-GEIGY AG (CH) | 1985-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221342-A1 | Process | PAH, TET2, PAM | KDM1A 351/4885MAOB 122/4885HDAC9 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.